Preclinical autophagy modulatory nanomedicines: big challenges, slow advances. (3rd October 2021)
- Record Type:
- Journal Article
- Title:
- Preclinical autophagy modulatory nanomedicines: big challenges, slow advances. (3rd October 2021)
- Main Title:
- Preclinical autophagy modulatory nanomedicines: big challenges, slow advances
- Authors:
- Romero, Eder Lilia
Morilla, Maria Jose - Abstract:
- ABSTRACT: Introduction: Autophagy is a critical housekeeping pathway to remove toxic protein aggregates, damaged organelles, providing cells with bioenergetic substrates needed to survive under adverse conditions. Since altered autophagy is associated with diverse diseases, its pharmacological modulation is considered of therapeutic interest. Nanomedicines may reduce the toxicity and improve the activity of toxic autophagy modulatory drugs ( amd ). Areas covered: The status of the most relevant anti-tumor, anti-inflammatory, and anti-infectious treatments mediated by autophagy modulatory nanomedicines (amN) published in the last 5 years is discussed. Expert opinion: Antitumor and anti-inflammatory treatments may be improved by administering amN for selective, massive, and targeted delivery of amd to diseased tissues. The use of amN as antimicrobial agent remains almost underexploited. Assessing the effect of amN on the complex autophagy machinery operating under different basal diseases, however, is not a trivial task. Besides structural reproducibility, nanomedicines must grant higher efficiency, and lower adverse effects than conventional medication. Simplicity of design, carefully chosen (scalable) preparation techniques, and rigorous monitoring of preclinical efficacy and nanotoxicity will improve the chances of clinical success. Currently, available data are not sufficient to envisage a fast-succeeding translation. Application of quality by design criteria would help toABSTRACT: Introduction: Autophagy is a critical housekeeping pathway to remove toxic protein aggregates, damaged organelles, providing cells with bioenergetic substrates needed to survive under adverse conditions. Since altered autophagy is associated with diverse diseases, its pharmacological modulation is considered of therapeutic interest. Nanomedicines may reduce the toxicity and improve the activity of toxic autophagy modulatory drugs ( amd ). Areas covered: The status of the most relevant anti-tumor, anti-inflammatory, and anti-infectious treatments mediated by autophagy modulatory nanomedicines (amN) published in the last 5 years is discussed. Expert opinion: Antitumor and anti-inflammatory treatments may be improved by administering amN for selective, massive, and targeted delivery of amd to diseased tissues. The use of amN as antimicrobial agent remains almost underexploited. Assessing the effect of amN on the complex autophagy machinery operating under different basal diseases, however, is not a trivial task. Besides structural reproducibility, nanomedicines must grant higher efficiency, and lower adverse effects than conventional medication. Simplicity of design, carefully chosen (scalable) preparation techniques, and rigorous monitoring of preclinical efficacy and nanotoxicity will improve the chances of clinical success. Currently, available data are not sufficient to envisage a fast-succeeding translation. Application of quality by design criteria would help to reach such milestones. … (more)
- Is Part Of:
- Expert opinion on drug delivery. Volume 18:Number 10(2021)
- Journal:
- Expert opinion on drug delivery
- Issue:
- Volume 18:Number 10(2021)
- Issue Display:
- Volume 18, Issue 10 (2021)
- Year:
- 2021
- Volume:
- 18
- Issue:
- 10
- Issue Sort Value:
- 2021-0018-0010-0000
- Page Start:
- 1415
- Page End:
- 1434
- Publication Date:
- 2021-10-03
- Subjects:
- Nanomedicines -- autophagy -- endocytosis -- targeted delivery -- toxicity -- quality by design
Drug delivery devices -- Periodicals
Drug delivery systems -- Periodicals
615.605 - Journal URLs:
- http://informahealthcare.com/journal/edd ↗
http://www.ashley-pub.com/?cookieSet=1 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/17425247.2021.1933428 ↗
- Languages:
- English
- ISSNs:
- 1742-5247
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002941
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19299.xml